All Pharma News
Roche, Adaptimmune part ways on cell therapy research

Roche, Adaptimmune part ways on cell therapy research
Jacob Bell BIOPHARMADIVE
13 Apr 2024
Share Share
GSK pays out £30M to Adaptimmune as cell therapy work ends

GSK pays out £30M to Adaptimmune as cell therapy work ends
Gabrielle Masson FIERCE BIOTECH
11 Apr 2023
Share Share
Adaptimmune & TCR² Announce Combination to Create Cell Therapy Company

Adaptimmune & TCR² Announce Combination to Create Cell Therapy Company
GLOBENEWSWIRE
06 Mar 2023
Share Share
Adaptimmune absorbs TCR² to extend cash runway, broaden pipeline

Adaptimmune absorbs TCR² to extend cash runway, broaden pipeline
James Waldron FIERCE BIOTECH
06 Mar 2023
Share Share
Adaptimmune to lay off up to 30% of staff amid pipeline shift

Adaptimmune to lay off up to 30% of staff amid pipeline shift
Max Bayer FIERCEBIOTECH
08 Nov 2022
Share Share
GSK axes Lyell cell therapy, passes programs to Adaptimmune

GSK axes Lyell cell therapy, passes programs to Adaptimmune
Nick Paul Taylor FIERCEBIOTECH
26 Oct 2022
Share Share
GSK deals cell therapy another setback

GSK deals cell therapy another setback
EVALUATE
25 Oct 2022
Share Share
Adaptimmune Reports Positive Data in its SURPASS Trial

Adaptimmune Reports Positive Data in its SURPASS Trial
ADAPTIMMUNE
09 Sep 2022
Share Share
Adaptimmune touts new PhI data for its cell therapy treatment

Adaptimmune touts new PhI data for its cell therapy treatment
Tyler Patchen ENDPTS
09 Sep 2022
Share Share
Adaptimmune Announces Appointment of Joanna Brewer as Chief Scientific Officer

Adaptimmune Announces Appointment of Joanna Brewer as Chief Scientific Officer
GLOBENEWSWIRE
04 May 2022
Share Share